Form 4: Intuitive Surgical Exec's RSU Vesting & Tax Sale

Intuitive Surgical's SVP & Chief Manufacturing and Supply Chain, Mark Brosius, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.

Summary

• Mark Brosius, SVP & Chief Manufacturing and Supply Chain at Intuitive Surgical Inc. (ISRG), reported transactions on February 10, 2026.
• 838 Restricted Stock Units (RSUs) vested and converted into common stock.
• 433 shares were disposed of at a price of $492.84 per share to cover statutory tax withholding requirements related to the RSU vesting.
• Following these transactions, Brosius beneficially owns 592 shares of common stock directly.
• He also holds 838 Restricted Stock Units (RSUs) that represent a contingent right to receive one share of common stock upon vesting, with 25% vesting annually from February 10, 2023.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, reflecting routine executive compensation and tax management rather than a strategic move or a reflection of company performance.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into executive compensation and stock ownership changes. These routine vesting and tax-related sales are common across the medical device and technology sectors for executives receiving equity compensation.

Comparison to Industry Standards

• This is a standard Form 4 filing, typical for executives in publicly traded companies across various industries, including medical technology firms like Medtronic or Johnson & Johnson, where equity compensation often includes RSUs that vest over time.
• The reported transactions align with common practices for managing executive stock awards and tax obligations.

Stakeholder Impact

• Shareholders: Minor dilution from RSU vesting, but offset by tax-related sale. Overall, minimal direct impact on existing shareholders from this routine transaction.
• Employees: No direct impact on employees.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event involving the vesting of Restricted Stock Units (RSUs) and a subsequent sale of shares to cover tax obligations. Such transactions are standard and do not typically reflect a change in the company's fundamental performance or outlook. Therefore, it provides no new information that would warrant a change in investment recommendation, suggesting a 'hold' position based solely on this filing.

Keywords

Intuitive Surgical, ISRG, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Executive Compensation, Mark Brosius, Stock Sale, Tax Withholding